http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20150093405-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69f43505d1b3ec31c224b32b5d1ec4e2 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2014-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_834136a81d002beda6aa863dc3811215 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc7905eb03ccacaae9bfc15938aff1a6 |
| publicationDate | 2015-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20150093405-A |
| titleOfInvention | Compositions for diagnosis of inflammation or metabolic syndrome induced by obesity |
| abstract | The present invention relates to a composition for diagnosing obesity-induced inflammation or metabolic syndrome comprising an antibody that specifically binds to a soluble 4-1BB protein, a diagnostic kit comprising the same, and a composition comprising the soluble 4-1BB protein for inducing obesity-induced inflammation Or a method for providing information necessary for diagnosis of metabolic syndrome. In accordance with the present invention, it has been demonstrated for the first time in the present invention that soluble 4-1BB protein is increased in obese adipose tissue and closely correlated with metabolic parameters. Therefore, the soluble 4-1BB protein of the present invention can be effectively used as a target for diagnosing or treating obesity-induced inflammation and metabolic syndrome. |
| priorityDate | 2014-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 437.